Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,670,111
+$162,990 QoQ
Shares Held
476,004
+0.6% QoQ
Ownership
0.320%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 329 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. PCVX ranks #55 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in PCVX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,670,111 | 476,004 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $27,507,121 | 473,363 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $15,509,635 | 336,143 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $12,106,535 | 336,106 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,535,828 | 939,275 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $116,641,846 | 3,089,032 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $234,883,515 | 2,869,332 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $318,394,499 | 2,786,335 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $185,888,629 | 2,461,775 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $146,706,379 | 2,147,656 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $67,630,575 | 1,076,920 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $48,733,565 | 955,935 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $37,574,805 | 752,399 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,844,637 | 716,239 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $249,339 | 5,200 | Shares | Defined | 2023-02-10 | |
| 2020-12-31 | $10,630,019 | 400,076 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $19,755,456 | 400,070 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,646,212 | 400,070 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||